Initial Statement of Beneficial Ownership (3)
January 11 2019 - 4:17PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Johnson Scott C.
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
1/1/2019
|
3. Issuer Name
and
Ticker or Trading Symbol
EXACT SCIENCES CORP [EXAS]
|
(Last)
(First)
(Middle)
C/O EXACT SCIENCES CORP., 441 CHARMANY DRIVE
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___
X
___ Officer (give title below)
_____ Other (specify below)
SVP - Research and Development /
|
(Street)
MADISON, WI 53719
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Common Stock
|
5293
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Restricted Stock Units
|
(1)
|
(1)
|
Common Stock
|
22500
|
$0.00
|
D
|
|
Restricted Stock Units
|
(2)
|
(2)
|
Common Stock
|
14100
|
$0.00
|
D
|
|
Stock Option (right to buy)
|
(3)
|
(3)
|
Common Stock
|
9012
|
$44.37
|
D
|
|
Stock Option (right to buy)
|
(3)
|
(3)
|
Common Stock
|
2688
|
$44.37
|
D
|
|
Explanation of Responses:
|
(1)
|
Represents a restricted stock unit award granted on September 11, 2017 that partially vested on September 11, 2018. The restricted stock units vest in four equal annual installments beginning on September 11, 2018.
|
(2)
|
These restricted stock units vest in four equal annual installments beginning on February 27, 2019, the first anniversary of the grant date.
|
(3)
|
These options vest and become exercisable in four equal annual installments beginning on February 27, 2019, the first anniversary of the grant date.
|
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Johnson Scott C.
C/O EXACT SCIENCES CORP.
441 CHARMANY DRIVE
MADISON, WI 53719
|
|
|
SVP - Research and Development
|
|
Signatures
|
/s/ Scott C. Johnson by Mark Busch, attorney-in-fact
|
|
1/11/2019
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Aug 2024 to Sep 2024
EXACT Sciences (NASDAQ:EXAS)
Historical Stock Chart
From Sep 2023 to Sep 2024